Breast cancer detection rates have improved by more than 10% through the integration of an artificial intelligence tool, according to a recent study led by the University of Aberdeen. This research, conducted in conjunction with an NHS Grampian project, involved over 10,000 women and demonstrated that the AI software significantly aids healthcare professionals in routine breast screenings.
The AI tool, known as Mia, developed by medical technology company Kheiron, is designed to identify small and potentially undetectable areas of concern on mammogram scans. The findings, published in the Nature Cancer journal, revealed that the AI could increase detection rates by 10.4% while also reducing the workload for medical staff and decreasing the time taken to inform patients of their results.
Human Impact and Early Detection
One participant in the study, Yvonne Cook, a woman in her 60s from Aberdeen, shared her experience of the screening process. Cook opted into the AI research during what she believed would be a routine mammogram appointment in 2023. She was notified of a potential issue following a follow-up mammogram that the AI analysis had flagged.
“I just feel incredibly lucky,” Cook remarked, reflecting on how the AI’s detection led to the early identification and treatment of a small, Grade 2 tumor. According to her, had the AI not detected the tumor, it might have been discovered at her next routine appointment three years later or only after it had grown larger.
Cook’s course of treatment included immediate medication to inhibit tumor growth, followed by surgery. She expressed concern over the potential consequences of a delayed diagnosis, including the possibility of more invasive surgery and a longer recovery period.
Significance of AI in Healthcare
The research team emphasized the implications of their findings, describing them as “hugely significant.” Early detection is crucial in increasing the chances of successful treatment, ultimately improving patient outcomes.
Professor Gerald Lip, clinical director for breast screening in northeast Scotland, highlighted the ability of AI to effectively support healthcare services. He stated, “The bottom line here is without AI, doctors would not have caught these cancers as early.”
As the healthcare sector continues to explore the integration of AI technologies, the findings from this study will play a critical role in shaping discussions around AI’s operational challenges in clinical practice over the next decade.
The ongoing trials will further assess the efficacy of the AI tool in breast screening across various locations in the UK, underscoring a growing commitment to harnessing technology for improved health outcomes.
